Front Page Demo Slide

HIPPA & HL7

1
2
3
4
LATEST NEWS:   VA health systems vary widely in heart disease death rates - (Reuters Health) - Heart disease death rates vary substantially at Veterans Affairs hospitals nationwide, and a new study suggests that this holds true not just for hospitalized patients but also for outpatients.
LATEST NEWS:   Women who freeze eggs to delay childbirth often feel regret - (Reuters Health) - For the past four years, since Facebook and Apple began paying for employees to freeze their eggs to delay childbirth, healthy women are increasingly trying to slow their biological clocks by banking their oocytes, or eggs.
LATEST NEWS:   Food insecurity linked to type 2 diabetes risk - (Reuters Health) - Canadians who cannot afford to eat regularly or to eat a healthy diet have more than double the average risk of developing type 2 diabetes, a study suggests.
LATEST NEWS:   Fear and suspicion hinder Congo medics in Ebola battle - DAKAR (Reuters) - With more than twice as many Ebola outbreaks as any other country since the virus was discovered in 1976, Congolese are familiar with its destructive power, yet fear and suspicion of medical authorities are still hindering efforts at containment.
LATEST NEWS:   Third Indian state checks suspect cases in outbreak of rare brain-damaging virus - MUMBAI (Reuters) - Officials in a third Indian state were checking on Friday if two people had been infected with the brain-damaging Nipah virus that has killed 12 in southern Kerala, although the government described the outbreak as minor.
LATEST NEWS:   AstraZeneca cancer drug hits second goal by extending survival - LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has hit a second important goal by improving overall survival in lung cancer patients, boosting prospects for a medicine that has already got off to a promising commercial launch.
LATEST NEWS:   Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales - MELBOURNE (Reuters) - An Australian court dismissed an appeal by the nation's anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its market power to limit competition for its cholesterol-lowering drug Lipitor.
LATEST NEWS:   FDA approves BioMarin rare metabolic disorder drug, shares rise - (Reuters) - U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours.
LATEST NEWS:   Pressured by industry, U.S. EPA slows formaldehyde study release: documents - WASHINGTON (Reuters) - The U.S. Environmental Protection Agency, under pressure from the chemical industry, has delayed release of a study detailing cancer risks from formaldehyde, according to internal communications seen by Reuters, potentially keeping important health information from the public.